Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report

Multidrug-resistant Acinetobacter baumannii infections: current evidence on treatment options and role of PK/PD in dose optimization

(2019) Sazlyna Mohd Sazlly Lim et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

(2019) George G. Zhanel et al.   DRUGS

Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis

(2019) Xingran Du et al.   AMERICAN JOURNAL OF INFECTION CONTROL

T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood

(2018) Giulia De Angelis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections

(2018) Burcu Isler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model

(2017) Xuejiu Cai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION